Synthesis, characterization and antitumor activity of novel octahedral Pt(IV) complexes.

作者: Young-Ee Kwon , Kyu-Ja Whang , Young-Ja Park , Kuk Hwan Kim

DOI: 10.1016/S0968-0896(03)00044-0

关键词: Chemical synthesisNuclear magnetic resonance spectroscopyChemistryCarboxylateMoleculeOctahedronStereochemistryPlatinumMalonateDiamine

摘要: Novel platinum(IV) complexes were synthesized having octahedral structure for new antitumor agents. The series of (1,4-butanediamine)Pt(IV) the type trans,cis-[PtA(2)Cl(2)(1,4-butanediamine)] (A=hydroxo 9, acetato 12, trifluoroacetato 13 as axial ligands) and trans-[PtA(2)(malonate)(1,4-butanediamine)] 16, 17, 18) characterized by IR, NMR elemental analysis. molecular structures 18 have been determined X-ray diffraction methods. crystals are monoclinic, P2 1/c with a=21.165 (5), b=9.050 (3), c=15.293 (3) A, beta=103.89 (2) degrees Z=8 a=10.178 b=12.894 (9), c=12.182 (8) beta=91.01 (5) Z=4 a=10.460 b=11.199 (8), c=15.641 (7) beta=98.41 degrees, 18. Three crystallographically independent molecules coordination around Pt(IV) cation. prepared acetylation or trifluoroacetylation trans,cis-[Pt(OH)(2)Cl(2)(1,4-butanediamine)]. trans-[PtA(2)malonate(1,4-butanediamine)] 17 was a similar method. in vitro cytotoxicity theses evaluated against 12 cancer cell lines assayed MTS IC(50) values compounds shown to be lower than those cisplatin. vivo activity using mice bearing L1210 leukemia, B16 melanoma L1210/cis-DDP animal models. compound found highest cisplatin-resistant cells, L1210/cis-DDP, vivo.

参考文章(16)
Christopher M. George, Dan J. Haraf, Ann M. Mauer, Stuart A. Krauss, Philip C. Hoffman, Charles M. Rudin, Livia Szeto, Everett E. Vokes, A phase I trial of the oral platinum analogue JM216 with concomitant radiotherapy in advanced malignancies of the chest. Investigational New Drugs. ,vol. 19, pp. 303- 310 ,(2001) , 10.1023/A:1010653508700
Brenda J. Foster, Kathleen Clagett-Carr, Brian Leyland-Jones, Daniel Hoth, Results of NCI-sponsored phase I trials with carboplatin. Cancer Treatment Reviews. ,vol. 12, pp. 43- 49 ,(1985) , 10.1016/0305-7372(85)90017-9
BARNETT ROSENBERG, LORETTA VANCAMP, JAMES E. TROSKO, VIRGINIA H. MANSOUR, Platinum Compounds: a New Class of Potent Antitumour Agents Nature. ,vol. 222, pp. 385- 386 ,(1969) , 10.1038/222385A0
L. Pendyala, Y. Kidani, R. Perez, J. Wilkes, R.J. Bernacki, P.J. Creaven, Cytotoxicity, cellular accumulation and DNA binding of oxaliplatin isomers Cancer Letters. ,vol. 97, pp. 177- 184 ,(1995) , 10.1016/0304-3835(95)03974-2
Renzo Canetta, Marcel Rozencweig, Stephen K. Carter, Carboplatin: the clinical spectrum to date. Cancer Treatment Reviews. ,vol. 12, pp. 125- 136 ,(1985) , 10.1016/0305-7372(85)90027-1
Young-A Lee, Sung Sil Lee, Kwan Mook Kim, Chong Ock Lee, Youn Soo Sohn, Synthesis and oral antitumor activity of tetrakis(carboxylato)platinum(IV) complexes. Journal of Medicinal Chemistry. ,vol. 43, pp. 1409- 1412 ,(2000) , 10.1021/JM9904250
S Rounaq Ali Khan, Shurong Huang, S Shamsuddin, Sadaaki Inutsuka, Kenton H Whitmire, Zahid H Siddik, Abdul R Khokhar, None, Synthesis, characterization and cytotoxicity of new platinum(IV) axial carboxylate complexes: crystal structure of potential antitumor agent [PtIV(trans-1R,2R-diaminocyclohexane)trans(acetate)2Cl2]. Bioorganic & Medicinal Chemistry. ,vol. 8, pp. 515- 521 ,(2000) , 10.1016/S0968-0896(99)00313-2
Taketo Mukaiyama, Ikuo Mitsui, Makoto Ogawa, Katsuhiro Inoue, In vitro evaluation of anticancer drugs in relation to development of drug resistance in the human tumor clonogenic assay. Cancer Chemotherapy and Pharmacology. ,vol. 15, pp. 208- 213 ,(1985) , 10.1007/BF00263887
Yoshihiro Kikuchi, Ichiro Iwano, Munenori Miyauchi, Tsunekazu Kita, Michio Sugita, Yoshio Tenjin, Ichiro Nagata, Possible Mechanisms of Resistance tocis-Diamminedichloroplatinum (II) of Human Ovarian Cancer Cells Japanese Journal of Cancer Research. ,vol. 81, pp. 701- 706 ,(1990) , 10.1111/J.1349-7006.1990.TB02630.X